BLUE Overview

Bluefin

0(0%)1D

No Data

24H High

0.0403

24H Low

0.03728

24H Volume

625.62K

24H Volatility

8.10%

All Time High

0.87663

All Time Low

0.03728

Correlation with BTC

0.61

Return On Investment

-51.40%

Bluefin is a decentralized spot and derivatives trading platform on the Sui blockchain and is backed by Polychain, SIG, Brevan Howard, and other leading firms. Bluefin is the largest protocol on Sui by total volume, with over $37B traded since launching in September 2023. The exchange currently has 57,754 unique depositors and $27.1M in TVL. The two core Bluefin products are:Decentralized Derivatives Trading: Bluefin’s derivatives product supports pre-launch markets and derivatives on ecosystem assets alongside the best execution prices for exposure to BTC, ETH, SOL and other major assets. Spot DEX: Bluefin’s spot AMM is the retail gateway in the ecosystem, powering both ecosystem assets and meme coins

Official Website Block Explorer Whitepaper

Social Media Sentiment

Bullish

0 Bullish

0 Neutral

0 Bearish

The current sentiment of Bitcoin (BLUE) on social media as of December 13, 2025 indicates a Bullish rating, with 0 users expressing a positive Bullish sentiment, 0 users opting for a Neutral, and 0 users suggesting a Bearish. This reflects a generally optimistic outlook among social media participants regarding BLUE's future outlook. While social media sentiment can provide valuable insights into public perception and market trends, its reliability as a sole reference for cryptocurrency investment decisions is limited. The data is often influenced by a small, vocal subset of users, which may not represent the broader market or include professional analysis. Factors such as hype, manipulation, or coordinated campaigns can skew sentiment, reducing its accuracy.

KY30007384h ago

$BLUE 70QTC, payer approval, worldwide rights still intact, 3 drugs. 60$mill MC. This is real shit show

KY30007385h ago

$BLUE Andy just sell this nightmare, 250-500$ mill firesale, this is pointless as a public company

lextrading8334h ago

$SGMO This should surprise no one. Why would Pfizer want a rare disease asset when they completely shut down their rare disease department? This is not a Pfizer thing. It's an industry thing. Takeda shut down their Rare Disease department. Novartis sold their AAV manufacturing sites. $BLUE $CRSP stock are struggling despite getting approvals. Gene therapies and editors are struggling.

gargoyl8650h ago

$BLUE MM likes drop the final trough of purchasing shares in last 20 min day. We should consolidate here , pivot at 2PM then pop at 3:40 Hold , average in , buy